Logiscreen

Stoke Therapeutics Inc

$29.39
Market Cap 1.74B
ROE -48.8%
Gross Margin 100.0%
Debt/Equity 0.0
Current Ratio 9.0
Revenue QoQ -96.1%
EPS QoQ -1.4%
F-Score 2

About

Stoke Therapeutics Inc

Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-10.93
vs median 36.93
P/B
4.70
vs median 2.32
ROE
-0.49
vs median 0.09

Lower quality - review fundamentals carefully

Small-cap company with higher volatility

Similar companies

GLUEURGNRXRXPGENATAIGENB
Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics